Previous Article | Next Article ![]()
Journal of Clinical Microbiology, August 2001, p. 2891-2896, Vol. 39, No. 8
Department of Biomedical
Sciences,1 Department of Microbiological
and Gynecological Sciences,3 and
Microbiological Laboratory, Policlinico,4
University of Catania, Catania, Italy, and School of
Biosciences, Cardiff University, Cardiff, Wales, United
Kingdom2
Received 17 January 2001/Returned for modification 14 March
2001/Accepted 7 May 2001
The prevalence, epidemiology, and genomovar status of
Burkholderia cepacia complex strains recovered from
Italian cystic fibrosis (CF) patients were investigated using genetic
typing and species identification methods. Four CF treatment centers
were examined: two in Sicily, one in central Italy, and one in northern
Italy. B. cepacia complex bacteria were
isolated from 59 out of 683 CF patients attending these centers
(8.6%). For the two geographically related treatment centers in
Sicily, there was a high incidence of infection caused by a single
epidemic clone possessing the cblA gene and belonging to
B. cepacia genomovar III, recA group III-A, closely related to the major North America-United Kingdom clone,
ET12; instability of the cblA sequence was also
demonstrated for clonal isolates. In summary, of all the strains of
B. cepacia encountered in the Italian CF population, the
genomovar III, recA group III-A strains were the most
prevalent and transmissible. However, patient-to-patient spread was
also observed with several other genomovars, including strains of novel
taxonomic status within the B. cepacia complex. A
combination of genetic identification and molecular typing analysis is
recommended to fully define specific risks posed by the genomovar
status of strains within the B. cepacia complex.
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.8.2891-2896.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Burkholderia cepacia Complex
Infection in Italian Patients with Cystic Fibrosis: Prevalence,
Epidemiology, and Genomovar Status
*
Corresponding author. Mailing address: Section of
Microbiology of the Department of Microbiological and Gynecological
Sciences, University of Catania, Via Androne 81, 95124 Catania, Italy.
Phone: 39 (095) 311352. Fax: 39 (095) 325032. E-mail:
stefanis{at}mbox.unict.it.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|